Kwality Pharmaceuticals Limited has issued a regulatory intimation to BSE Limited pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board of Directors meeting is scheduled for Thursday, November 12, 2026, at 10:30 A.M. at the company's registered office in Village Nagkalan, Majitha Road, Amritsar, Punjab-143601.
The agenda for the meeting includes:
- Consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.
- Consideration of any other business with the permission of the Chair.
The company also confirmed the continuation of the trading window closure for all designated persons, their immediate relatives, and other connected persons. The trading window had been closed since the previous intimation dated September 28, 2026, and will remain closed until 48 hours after the declaration of the financial results on November 12, 2026.
The communication was signed by Ramesh Kumar, Managing Director (DIN: 00462656).